Impact of Vaccines Across the Lifespan: A New Perspective in Public Health—Conclusions of an Expert Panel—Part 1 †
- Roberto Debbag,
- María L. Ávila-Agüero,
- José Brea,
- Carlos Espinal,
- Rodrigo Romero-Feregrino,
- Jaime R. Torres
- Latin-American Vaccinology Society,
- Yale School of Medicine and Yale School of Public Health,
- Hospital Nacional de Niños,
- Instituto Tecnológico de Santo Domingo - INTEC,
- Florida International University,
- Instituto Mexicano del Seguro Social
Open access
Publication Information
Output type
Original language
EnglishArticle number
183Journal (Volume, Issue Number)
Vaccines (Volume 14, Issue 2)Publication milestones
- Published - 02/2026
Publication status
Publication IDs
- Scopus: 105031447802
Abstract
Population aging is the most significant demographic transformation of the 21st century, reshaping health systems, economies, and societies. The biological processes of immunosenescence and inflammaging weaken host defenses, reduce vaccine effectiveness, and increase vulnerability to infectious and chronic diseases. These changes underscore the urgent need for preventive strategies that extend beyond childhood immunization. Vaccination is a cornerstone of healthy aging, capable of preventing infections and has been associated with reductions in systemic inflammation, frailty, and loss of functional independence in later life. Furthermore, new insights into vaccine-mediated immunomodulation, including trained immunity, adjuvanted formulations, and epigenetic reprogramming, highlight the evolving role of vaccines as modulators of immune fitness across the lifespan. This first part of our review examines the intersection of aging and immunity, as well as the potential of vaccines to address these challenges. Part 2 will expand on specific vaccines, proposed vaccination schedules, and global perspectives for lifelong immunization.
Access to documents
Publication metrics
Metrics
Sustainable Development Goals
- SDG 3 Good Health and Well
